QSV Equity Investors’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$229K Sell
2,849
-130
-4% -$10.5K 0.34% 86
2025
Q3
$244K Sell
2,979
-71
-2% -$6.15K 0.25% 87
2025
Q2
$278K Sell
3,050
-3
-0.1% -$268 0.29% 78
2025
Q1
$279K Sell
3,053
-14
-0.5% -$1.22K 0.29% 75
2024
Q4
$261K Buy
3,067
+18
+0.6% +$1.58K 0.25% 78
2024
Q3
$267K Hold
3,049
0.25% 79
2024
Q2
$241K Sell
3,049
-274
-8% -$22.5K 0.25% 76
2024
Q1
$300K Buy
3,323
+211
+7% +$19.2K 0.29% 80
2023
Q4
$274K Buy
+3,112
New +$259K 0.27% 83

Other funds holding DOX

QSV Equity Investors's DOX Position: Q4 2025 in Review

QSV Equity Investors reduced its Amdocs (DOX) stake by 4.4% in Q4 2025, selling an estimated $10.5K and leaving 2,849 shares worth $229K. The position accounts for 0.34% of the portfolio, ranked #86.

QSV Equity Investors first reported a position in DOX in Q4 2023 and has held it in 9 quarters since. The position peaked at $300K in Q1 2024. 492 funds tracked by Wall St. Rank hold DOX as of Q4 2025.

  • QSV Equity Investors held 2,849 shares of Amdocs worth $229K as of Q4 2025.
  • QSV Equity Investors sold 130 Amdocs shares in Q4 2025, an estimated $10.5K.
  • Amdocs made up 0.34% of QSV Equity Investors's portfolio in Q4 2025, its #86 holding.
  • QSV Equity Investors first reported a position in Amdocs in Q4 2023 and has held it in 9 quarters since.
  • QSV Equity Investors's Amdocs position peaked at $300K in Q1 2024.
  • 492 funds tracked by Wall St. Rank held Amdocs as of Q4 2025.

Based on QSV Equity Investors's 13F filing for Q4 2025, filed 12 Feb 2026.